1. Home
  2. CATO vs MNOV Comparison

CATO vs MNOV Comparison

Compare CATO & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

HOLD

Current Price

$2.66

Market Cap

67.9M

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.42

Market Cap

68.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATO
MNOV
Founded
1946
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.9M
68.4M
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
CATO
MNOV
Price
$2.66
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
164.1K
37.2K
Earning Date
05-21-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
68.04
N/A
EPS
0.47
N/A
Revenue
$653,812,000.00
$2,360,807.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$180.00
P/E Ratio
$5.89
N/A
Revenue Growth
0.62
194.15
52 Week Low
$2.59
$1.17
52 Week High
$4.92
$1.96

Technical Indicators

Market Signals
Indicator
CATO
MNOV
Relative Strength Index (RSI) 35.07 56.54
Support Level N/A $1.27
Resistance Level $3.62 $1.55
Average True Range (ATR) 0.19 0.07
MACD -0.08 0.02
Stochastic Oscillator 4.87 49.98

Price Performance

Historical Comparison
CATO
MNOV

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: